๐ฆ๐ฎ๐บ๐๐๐ป๐ด ๐๐ป๐๐ฒ๐ถ๐น๐ ๐ฎ $๐ฎ๐ฌ๐ฑ ๐ฏ๐ถ๐น๐น๐ถ๐ผ๐ป ๐ฒ๐
๐ฝ๐ฎ๐ป๐๐ถ๐ผ๐ป ๐ฝ๐น๐ฎ๐ป ๐๐ต๐ฎ๐ ๐๐ถ๐น๐น ๐ด๐ฒ๐ป๐ฒ๐ฟ๐ฎ๐๐ฒ ๐ฐ๐ฌ,๐ฌ๐ฌ๐ฌ ๐ท๐ผ๐ฏ๐.
$SMSN.L (Samsung Electronics Co Ltd) has announced a 240 trillion Korean Won (roughly $205 billion) expansion in diversified divisions over the next three years, including chipmaking, biopharmaceuticals, and telecommunications units. It intends to enhance its global presence and lean in new industries such as next-generation telecommunications and robotics.
Samsung Electronics plans to develop advanced process technology and expand the business with artificial intelligence (AI) and data centers for its system semiconductors while focusing on up-to-date technology. Last May, the company announced it would invest $151 billion in its logic chip and foundry sector to be the top logic chip maker by 2030.
Samsung Biologics and Samsung Bioepis plan to establish two new plants for expanding the contract development manufacturing organization (CDMO) business. The CDMO unit is set to manufacture
MRNA (Moderna Inc) โs Covid-19 vaccine at its facilities in South Korea late this month.
Samsung said it would be aggressive for big acquisition deals to pave its leadership in its target businesses. It is currently sitting on about 200 trillion won cash and cash-equivalent assets.
South Koreaโs largest conglomerate is setting aside 180 trillion won for its home country alone. It now aims to hire another 10,000 people over the period, on top of 30,000 new jobs already planned
$SMSN.L (Samsung Electronics Co Ltd) has announced a 240 trillion Korean Won (roughly $205 billion) expansion in diversified divisions over the next three years, including chipmaking, biopharmaceuticals, and telecommunications units. It intends to enhance its global presence and lean in new industries such as next-generation telecommunications and robotics.
Samsung Electronics plans to develop advanced process technology and expand the business with artificial intelligence (AI) and data centers for its system semiconductors while focusing on up-to-date technology. Last May, the company announced it would invest $151 billion in its logic chip and foundry sector to be the top logic chip maker by 2030.
Samsung Biologics and Samsung Bioepis plan to establish two new plants for expanding the contract development manufacturing organization (CDMO) business. The CDMO unit is set to manufacture
MRNA (Moderna Inc) โs Covid-19 vaccine at its facilities in South Korea late this month.Samsung said it would be aggressive for big acquisition deals to pave its leadership in its target businesses. It is currently sitting on about 200 trillion won cash and cash-equivalent assets.
South Koreaโs largest conglomerate is setting aside 180 trillion won for its home country alone. It now aims to hire another 10,000 people over the period, on top of 30,000 new jobs already planned
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.